Metformin in COVID-19: clinical trials are needed to prove its benefits.
作者信息
Kow Chia Siang, Ramachandram Dinesh Sangarran, Hasan Syed Shahzad
机构信息
School of Postgraduate Studies, International Medical University, Kuala Lumpur, Malaysia.
School of Pharmacy, Monash University Malaysia, Bandar Sunway, Subang Jaya, Selangor, Malaysia.
出版信息
Ir J Med Sci. 2022 Dec;191(6):2641-2642. doi: 10.1007/s11845-021-02869-9. Epub 2022 Jan 8.
Abstract
摘要
相似文献
1
Metformin in COVID-19: clinical trials are needed to prove its benefits.二甲双胍用于治疗新型冠状病毒肺炎：需要通过临床试验来证明其益处。
Ir J Med Sci. 2022 Dec;191(6):2641-2642. doi: 10.1007/s11845-021-02869-9. Epub 2022 Jan 8.
2
Response to "Metformin use and risk of COVID-19 among patients with type II diabetes mellitus: an NHIS-COVID-19 database cohort study".对“2型糖尿病患者使用二甲双胍与感染2019冠状病毒病的风险：一项韩国国民健康保险服务-2019冠状病毒病数据库队列研究”的回应
Acta Diabetol. 2022 Jun;59(6):869-870. doi: 10.1007/s00592-022-01861-8. Epub 2022 Mar 4.
3
Is metformin a miracle or a menace in COVID-19 patients with type 2 diabetes?二甲双胍在 2 型糖尿病合并 COVID-19 患者中是“灵丹妙药”还是“洪水猛兽”？
J Diabetes Investig. 2021 Apr;12(4):479-481. doi: 10.1111/jdi.13484. Epub 2021 Jan 18.
4
WITHDRAWN: Metformin monotherapy for type 2 diabetes mellitus.撤回：二甲双胍单药治疗2型糖尿病。
Cochrane Database Syst Rev. 2015 Sep 30(9):CD002966. doi: 10.1002/14651858.CD002966.pub4.
5
Is there an association between metformin use and clinical outcomes in diabetes patients with COVID-19?在 COVID-19 患者中，使用二甲双胍与临床结局之间是否存在关联？
Diabetes Metab. 2021 Jul;47(4):101208. doi: 10.1016/j.diabet.2020.10.006. Epub 2020 Nov 4.
6
Comments on "Comparison of repaglinide and metformin versus metformin alone for type 2 diabetes: a meta-analysis of randomized controlled trials".对“瑞格列奈与二甲双胍联合用药对比单用二甲双胍治疗2型糖尿病：一项随机对照试验的荟萃分析”的评论
Diabetes Res Clin Pract. 2015 Apr;108(1):e1-2. doi: 10.1016/j.diabres.2015.02.004. Epub 2015 Feb 21.
7
Effects of metformin, insulin on COVID-19 patients with pre-existed type 2 diabetes: A multicentral retrospective study.二甲双胍和胰岛素对合并 2 型糖尿病的 COVID-19 患者的影响：一项多中心回顾性研究。
Life Sci. 2021 Jun 15;275:119371. doi: 10.1016/j.lfs.2021.119371. Epub 2021 Mar 19.
8
Metformin: are potential benefits on cancer risk extended to cancer survival?二甲双胍：对癌症风险的潜在益处会延伸至癌症生存吗？
Oncologist. 2013;18(12):1245-7. doi: 10.1634/theoncologist.2013-0381. Epub 2013 Nov 20.
9
[Therapeutic renaissance. Biguanides in type-2 diabetes: metformin].[治疗的复兴。2型糖尿病中的双胍类药物：二甲双胍]
Pharm Unserer Zeit. 2002;31(3):264-70. doi: 10.1002/1615-1003(200205)31:3<264::AID-PAUZ264>3.0.CO;2-D.
10
Pioglitazone/metformin (Actoplus met).吡格列酮/二甲双胍（复方制剂，商品名：Actoplus met）
Med Lett Drugs Ther. 2006 Jan 30;48(1227):9-11.
本文引用的文献
1
Metformin Use Is Associated with Decreased Mortality in COVID-19 Patients with Diabetes: Evidence from Retrospective Studies and Biological Mechanism.二甲双胍的使用与2型糖尿病合并COVID-19患者死亡率降低相关：来自回顾性研究的证据及生物学机制
J Clin Med. 2021 Aug 9;10(16):3507. doi: 10.3390/jcm10163507.
2
Pitfalls in Reporting Sample Size Calculation Across Randomized Controlled Trials Involving Ivermectin for the treatment of COVID-19.在报告涉及使用伊维菌素治疗新冠肺炎的随机对照试验中的样本量计算时存在的陷阱。
Am J Ther. 2021 Aug 6;28(5):e616-e619. doi: 10.1097/MJT.0000000000001441.
3
The Effect of Metformin Consumption on Mortality in Hospitalized COVID-19 patients: a systematic review and meta-analysis.二甲双胍对住院 COVID-19 患者死亡率的影响：系统评价和荟萃分析。
Diabetes Metab Syndr. 2020 Nov-Dec;14(6):2177-2183. doi: 10.1016/j.dsx.2020.11.006. Epub 2020 Nov 11.
4
Mortality risk with preadmission metformin use in patients with COVID-19 and diabetes: A meta-analysis.2019冠状病毒病合并糖尿病患者入院前使用二甲双胍的死亡风险：一项荟萃分析。
J Med Virol. 2021 Feb;93(2):695-697. doi: 10.1002/jmv.26498. Epub 2020 Sep 30.
5
Metformin use amid coronavirus disease 2019 pandemic.2019年冠状病毒病大流行期间二甲双胍的使用情况
J Med Virol. 2020 Nov;92(11):2401-2402. doi: 10.1002/jmv.26090. Epub 2020 Jun 9.
6
Association of preadmission metformin use and mortality in patients with sepsis and diabetes mellitus: a systematic review and meta-analysis of cohort studies.糖尿病合并脓毒症患者入院前使用二甲双胍与死亡率的相关性：队列研究的系统评价和荟萃分析。
Crit Care. 2019 Feb 18;23(1):50. doi: 10.1186/s13054-019-2346-4.
Zotero 插件